Algorithmic Genesis & Biological Computation

Building better worlds. Accelerating drug discovery, genomic synthesis, and adaptive therapies through decentralized intelligence substrates running on bare-metal silicon.

Access Terminal

Clinical Pipeline & Biological Assets

Investigational compounds and synthetic biologics currently undergoing evolutionary pressure on the YutaniAI compute fabric.

Molecule / Compound
Therapeutic Focus
Development Phase
Y-XENO-01
Accelerated Cellular Regeneration (mRNA)
Phase 1
PROMETHEUS-V
Deep-Space Radiation Resistance Vector
Phase 2
ACHERON-426
Atmospheric Bio-Processing / Synthetic Algae
Phase 3
DAVID-8 SYNAPSE
Neural Substrate Integration & Cybernetics
Commercial
* Investigational biological agents are strictly regulated by the Interstellar Commerce Commission (ICC). Safety and efficacy have not yet been established. Access to Phase 1 data requires Level 4 Bio-Clearance.